nodes	percent_of_prediction	percent_of_DWPC	metapath
Telmisartan—ABCG2—Dactinomycin—testicular cancer	0.0825	0.103	CbGbCtD
Telmisartan—SLCO1B3—Methotrexate—testicular cancer	0.0665	0.0831	CbGbCtD
Telmisartan—ABCC2—Carboplatin—testicular cancer	0.0613	0.0766	CbGbCtD
Telmisartan—ABCC2—Vinblastine—testicular cancer	0.0572	0.0714	CbGbCtD
Telmisartan—ABCG2—Carboplatin—testicular cancer	0.0554	0.0693	CbGbCtD
Telmisartan—ABCC2—Cisplatin—testicular cancer	0.0524	0.0655	CbGbCtD
Telmisartan—ABCC2—Etoposide—testicular cancer	0.0515	0.0643	CbGbCtD
Telmisartan—ABCG2—Cisplatin—testicular cancer	0.0474	0.0592	CbGbCtD
Telmisartan—ABCG2—Etoposide—testicular cancer	0.0466	0.0582	CbGbCtD
Telmisartan—CYP2C19—Ifosfamide—testicular cancer	0.0435	0.0544	CbGbCtD
Telmisartan—ABCC2—Doxorubicin—testicular cancer	0.0351	0.0439	CbGbCtD
Telmisartan—ABCC2—Methotrexate—testicular cancer	0.034	0.0425	CbGbCtD
Telmisartan—ABCG2—Doxorubicin—testicular cancer	0.0318	0.0397	CbGbCtD
Telmisartan—ABCG2—Methotrexate—testicular cancer	0.0308	0.0384	CbGbCtD
Telmisartan—ABCB1—Dactinomycin—testicular cancer	0.0297	0.0372	CbGbCtD
Telmisartan—ABCB1—Vinblastine—testicular cancer	0.0186	0.0233	CbGbCtD
Telmisartan—ABCB1—Cisplatin—testicular cancer	0.0171	0.0213	CbGbCtD
Telmisartan—ABCB1—Etoposide—testicular cancer	0.0168	0.021	CbGbCtD
Telmisartan—ABCB1—Doxorubicin—testicular cancer	0.0114	0.0143	CbGbCtD
Telmisartan—ABCB1—Methotrexate—testicular cancer	0.0111	0.0139	CbGbCtD
Telmisartan—PPARG—Teniposide—Etoposide—testicular cancer	0.00352	1	CbGdCrCtD
Telmisartan—Infestation NOS—Doxorubicin—testicular cancer	0.000161	0.000821	CcSEcCtD
Telmisartan—Infestation—Doxorubicin—testicular cancer	0.000161	0.000821	CcSEcCtD
Telmisartan—Visual impairment—Methotrexate—testicular cancer	0.000161	0.000821	CcSEcCtD
Telmisartan—Vomiting—Ifosfamide—testicular cancer	0.000159	0.000813	CcSEcCtD
Telmisartan—Hypersensitivity—Cisplatin—testicular cancer	0.000159	0.000812	CcSEcCtD
Telmisartan—Bradycardia—Epirubicin—testicular cancer	0.000159	0.000811	CcSEcCtD
Telmisartan—Renal failure—Doxorubicin—testicular cancer	0.000158	0.000807	CcSEcCtD
Telmisartan—Rash—Ifosfamide—testicular cancer	0.000158	0.000806	CcSEcCtD
Telmisartan—Dermatitis—Ifosfamide—testicular cancer	0.000158	0.000806	CcSEcCtD
Telmisartan—Neuropathy peripheral—Doxorubicin—testicular cancer	0.000158	0.000805	CcSEcCtD
Telmisartan—Urticaria—Etoposide—testicular cancer	0.000157	0.000802	CcSEcCtD
Telmisartan—Rhinitis—Epirubicin—testicular cancer	0.000157	0.000799	CcSEcCtD
Telmisartan—Abdominal pain—Etoposide—testicular cancer	0.000157	0.000798	CcSEcCtD
Telmisartan—Body temperature increased—Etoposide—testicular cancer	0.000157	0.000798	CcSEcCtD
Telmisartan—Urinary tract infection—Doxorubicin—testicular cancer	0.000157	0.000798	CcSEcCtD
Telmisartan—Conjunctivitis—Doxorubicin—testicular cancer	0.000157	0.000798	CcSEcCtD
Telmisartan—Eye disorder—Methotrexate—testicular cancer	0.000156	0.000796	CcSEcCtD
Telmisartan—Tinnitus—Methotrexate—testicular cancer	0.000156	0.000794	CcSEcCtD
Telmisartan—Hypoaesthesia—Epirubicin—testicular cancer	0.000155	0.000793	CcSEcCtD
Telmisartan—Asthenia—Cisplatin—testicular cancer	0.000155	0.000791	CcSEcCtD
Telmisartan—Pharyngitis—Epirubicin—testicular cancer	0.000155	0.000791	CcSEcCtD
Telmisartan—Cardiac disorder—Methotrexate—testicular cancer	0.000155	0.00079	CcSEcCtD
Telmisartan—Urinary tract disorder—Epirubicin—testicular cancer	0.000154	0.000787	CcSEcCtD
Telmisartan—Oedema peripheral—Epirubicin—testicular cancer	0.000154	0.000785	CcSEcCtD
Telmisartan—Haematuria—Doxorubicin—testicular cancer	0.000154	0.000783	CcSEcCtD
Telmisartan—Connective tissue disorder—Epirubicin—testicular cancer	0.000154	0.000783	CcSEcCtD
Telmisartan—Urethral disorder—Epirubicin—testicular cancer	0.000153	0.000781	CcSEcCtD
Telmisartan—Hepatobiliary disease—Doxorubicin—testicular cancer	0.000152	0.000777	CcSEcCtD
Telmisartan—Epistaxis—Doxorubicin—testicular cancer	0.000152	0.000775	CcSEcCtD
Telmisartan—Angiopathy—Methotrexate—testicular cancer	0.000151	0.000773	CcSEcCtD
Telmisartan—Sinusitis—Doxorubicin—testicular cancer	0.000151	0.000771	CcSEcCtD
Telmisartan—Immune system disorder—Methotrexate—testicular cancer	0.000151	0.000769	CcSEcCtD
Telmisartan—Visual impairment—Epirubicin—testicular cancer	0.000151	0.000768	CcSEcCtD
Telmisartan—Mediastinal disorder—Methotrexate—testicular cancer	0.00015	0.000767	CcSEcCtD
Telmisartan—Chills—Methotrexate—testicular cancer	0.00015	0.000764	CcSEcCtD
Telmisartan—Nausea—Ifosfamide—testicular cancer	0.000149	0.00076	CcSEcCtD
Telmisartan—Diarrhoea—Cisplatin—testicular cancer	0.000148	0.000754	CcSEcCtD
Telmisartan—Bradycardia—Doxorubicin—testicular cancer	0.000147	0.000751	CcSEcCtD
Telmisartan—Mental disorder—Methotrexate—testicular cancer	0.000146	0.000746	CcSEcCtD
Telmisartan—Eye disorder—Epirubicin—testicular cancer	0.000146	0.000745	CcSEcCtD
Telmisartan—Hypersensitivity—Etoposide—testicular cancer	0.000146	0.000744	CcSEcCtD
Telmisartan—Tinnitus—Epirubicin—testicular cancer	0.000146	0.000743	CcSEcCtD
Telmisartan—Erythema—Methotrexate—testicular cancer	0.000145	0.000741	CcSEcCtD
Telmisartan—Malnutrition—Methotrexate—testicular cancer	0.000145	0.000741	CcSEcCtD
Telmisartan—Cardiac disorder—Epirubicin—testicular cancer	0.000145	0.00074	CcSEcCtD
Telmisartan—Flushing—Epirubicin—testicular cancer	0.000145	0.00074	CcSEcCtD
Telmisartan—Rhinitis—Doxorubicin—testicular cancer	0.000145	0.000739	CcSEcCtD
Telmisartan—Hypoaesthesia—Doxorubicin—testicular cancer	0.000144	0.000734	CcSEcCtD
Telmisartan—Pharyngitis—Doxorubicin—testicular cancer	0.000143	0.000732	CcSEcCtD
Telmisartan—Urinary tract disorder—Doxorubicin—testicular cancer	0.000143	0.000728	CcSEcCtD
Telmisartan—Oedema peripheral—Doxorubicin—testicular cancer	0.000142	0.000726	CcSEcCtD
Telmisartan—Dysgeusia—Methotrexate—testicular cancer	0.000142	0.000726	CcSEcCtD
Telmisartan—Asthenia—Etoposide—testicular cancer	0.000142	0.000725	CcSEcCtD
Telmisartan—Connective tissue disorder—Doxorubicin—testicular cancer	0.000142	0.000725	CcSEcCtD
Telmisartan—Angiopathy—Epirubicin—testicular cancer	0.000142	0.000723	CcSEcCtD
Telmisartan—Urethral disorder—Doxorubicin—testicular cancer	0.000142	0.000723	CcSEcCtD
Telmisartan—Immune system disorder—Epirubicin—testicular cancer	0.000141	0.00072	CcSEcCtD
Telmisartan—Mediastinal disorder—Epirubicin—testicular cancer	0.000141	0.000718	CcSEcCtD
Telmisartan—Back pain—Methotrexate—testicular cancer	0.000141	0.000717	CcSEcCtD
Telmisartan—Chills—Epirubicin—testicular cancer	0.00014	0.000715	CcSEcCtD
Telmisartan—Pruritus—Etoposide—testicular cancer	0.00014	0.000715	CcSEcCtD
Telmisartan—Arrhythmia—Epirubicin—testicular cancer	0.00014	0.000712	CcSEcCtD
Telmisartan—Visual impairment—Doxorubicin—testicular cancer	0.000139	0.000711	CcSEcCtD
Telmisartan—Vomiting—Cisplatin—testicular cancer	0.000137	0.000701	CcSEcCtD
Telmisartan—Mental disorder—Epirubicin—testicular cancer	0.000137	0.000698	CcSEcCtD
Telmisartan—Rash—Cisplatin—testicular cancer	0.000136	0.000695	CcSEcCtD
Telmisartan—Dermatitis—Cisplatin—testicular cancer	0.000136	0.000694	CcSEcCtD
Telmisartan—Malnutrition—Epirubicin—testicular cancer	0.000136	0.000694	CcSEcCtD
Telmisartan—Erythema—Epirubicin—testicular cancer	0.000136	0.000694	CcSEcCtD
Telmisartan—Diarrhoea—Etoposide—testicular cancer	0.000135	0.000691	CcSEcCtD
Telmisartan—Eye disorder—Doxorubicin—testicular cancer	0.000135	0.000689	CcSEcCtD
Telmisartan—Ill-defined disorder—Methotrexate—testicular cancer	0.000135	0.000688	CcSEcCtD
Telmisartan—Tinnitus—Doxorubicin—testicular cancer	0.000135	0.000687	CcSEcCtD
Telmisartan—Anaemia—Methotrexate—testicular cancer	0.000134	0.000685	CcSEcCtD
Telmisartan—Flushing—Doxorubicin—testicular cancer	0.000134	0.000684	CcSEcCtD
Telmisartan—Cardiac disorder—Doxorubicin—testicular cancer	0.000134	0.000684	CcSEcCtD
Telmisartan—Flatulence—Epirubicin—testicular cancer	0.000134	0.000684	CcSEcCtD
Telmisartan—Tension—Epirubicin—testicular cancer	0.000133	0.000681	CcSEcCtD
Telmisartan—Dysgeusia—Epirubicin—testicular cancer	0.000133	0.000679	CcSEcCtD
Telmisartan—Nervousness—Epirubicin—testicular cancer	0.000132	0.000674	CcSEcCtD
Telmisartan—Back pain—Epirubicin—testicular cancer	0.000132	0.000671	CcSEcCtD
Telmisartan—Angiopathy—Doxorubicin—testicular cancer	0.000131	0.000669	CcSEcCtD
Telmisartan—Malaise—Methotrexate—testicular cancer	0.000131	0.000668	CcSEcCtD
Telmisartan—Dizziness—Etoposide—testicular cancer	0.000131	0.000668	CcSEcCtD
Telmisartan—Muscle spasms—Epirubicin—testicular cancer	0.000131	0.000667	CcSEcCtD
Telmisartan—Immune system disorder—Doxorubicin—testicular cancer	0.000131	0.000666	CcSEcCtD
Telmisartan—Vertigo—Methotrexate—testicular cancer	0.000131	0.000666	CcSEcCtD
Telmisartan—Mediastinal disorder—Doxorubicin—testicular cancer	0.00013	0.000665	CcSEcCtD
Telmisartan—Chills—Doxorubicin—testicular cancer	0.00013	0.000662	CcSEcCtD
Telmisartan—Arrhythmia—Doxorubicin—testicular cancer	0.000129	0.000659	CcSEcCtD
Telmisartan—Nausea—Cisplatin—testicular cancer	0.000128	0.000655	CcSEcCtD
Telmisartan—Cough—Methotrexate—testicular cancer	0.000127	0.000647	CcSEcCtD
Telmisartan—Mental disorder—Doxorubicin—testicular cancer	0.000127	0.000646	CcSEcCtD
Telmisartan—Ill-defined disorder—Epirubicin—testicular cancer	0.000126	0.000644	CcSEcCtD
Telmisartan—Vomiting—Etoposide—testicular cancer	0.000126	0.000642	CcSEcCtD
Telmisartan—Erythema—Doxorubicin—testicular cancer	0.000126	0.000642	CcSEcCtD
Telmisartan—Malnutrition—Doxorubicin—testicular cancer	0.000126	0.000642	CcSEcCtD
Telmisartan—Anaemia—Epirubicin—testicular cancer	0.000126	0.000641	CcSEcCtD
Telmisartan—Rash—Etoposide—testicular cancer	0.000125	0.000637	CcSEcCtD
Telmisartan—Dermatitis—Etoposide—testicular cancer	0.000125	0.000636	CcSEcCtD
Telmisartan—Headache—Etoposide—testicular cancer	0.000124	0.000633	CcSEcCtD
Telmisartan—Flatulence—Doxorubicin—testicular cancer	0.000124	0.000632	CcSEcCtD
Telmisartan—Myalgia—Methotrexate—testicular cancer	0.000124	0.000631	CcSEcCtD
Telmisartan—Arthralgia—Methotrexate—testicular cancer	0.000124	0.000631	CcSEcCtD
Telmisartan—Chest pain—Methotrexate—testicular cancer	0.000124	0.000631	CcSEcCtD
Telmisartan—Tension—Doxorubicin—testicular cancer	0.000123	0.00063	CcSEcCtD
Telmisartan—Dysgeusia—Doxorubicin—testicular cancer	0.000123	0.000629	CcSEcCtD
Telmisartan—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—testicular cancer	0.000123	0.000627	CcSEcCtD
Telmisartan—Malaise—Epirubicin—testicular cancer	0.000123	0.000626	CcSEcCtD
Telmisartan—Discomfort—Methotrexate—testicular cancer	0.000122	0.000624	CcSEcCtD
Telmisartan—Nervousness—Doxorubicin—testicular cancer	0.000122	0.000623	CcSEcCtD
Telmisartan—Vertigo—Epirubicin—testicular cancer	0.000122	0.000623	CcSEcCtD
Telmisartan—Syncope—Epirubicin—testicular cancer	0.000122	0.000622	CcSEcCtD
Telmisartan—Back pain—Doxorubicin—testicular cancer	0.000122	0.000621	CcSEcCtD
Telmisartan—Muscle spasms—Doxorubicin—testicular cancer	0.000121	0.000617	CcSEcCtD
Telmisartan—Palpitations—Epirubicin—testicular cancer	0.00012	0.000613	CcSEcCtD
Telmisartan—Loss of consciousness—Epirubicin—testicular cancer	0.00012	0.00061	CcSEcCtD
Telmisartan—Cough—Epirubicin—testicular cancer	0.000119	0.000605	CcSEcCtD
Telmisartan—Anaphylactic shock—Methotrexate—testicular cancer	0.000119	0.000605	CcSEcCtD
Telmisartan—Infection—Methotrexate—testicular cancer	0.000118	0.000601	CcSEcCtD
Telmisartan—Nausea—Etoposide—testicular cancer	0.000118	0.0006	CcSEcCtD
Telmisartan—Hypertension—Epirubicin—testicular cancer	0.000117	0.000599	CcSEcCtD
Telmisartan—Ill-defined disorder—Doxorubicin—testicular cancer	0.000117	0.000596	CcSEcCtD
Telmisartan—Nervous system disorder—Methotrexate—testicular cancer	0.000116	0.000593	CcSEcCtD
Telmisartan—Anaemia—Doxorubicin—testicular cancer	0.000116	0.000593	CcSEcCtD
Telmisartan—Thrombocytopenia—Methotrexate—testicular cancer	0.000116	0.000592	CcSEcCtD
Telmisartan—Chest pain—Epirubicin—testicular cancer	0.000116	0.000591	CcSEcCtD
Telmisartan—Arthralgia—Epirubicin—testicular cancer	0.000116	0.000591	CcSEcCtD
Telmisartan—Myalgia—Epirubicin—testicular cancer	0.000116	0.000591	CcSEcCtD
Telmisartan—Anxiety—Epirubicin—testicular cancer	0.000115	0.000589	CcSEcCtD
Telmisartan—Skin disorder—Methotrexate—testicular cancer	0.000115	0.000588	CcSEcCtD
Telmisartan—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—testicular cancer	0.000115	0.000587	CcSEcCtD
Telmisartan—Hyperhidrosis—Methotrexate—testicular cancer	0.000115	0.000585	CcSEcCtD
Telmisartan—Discomfort—Epirubicin—testicular cancer	0.000114	0.000584	CcSEcCtD
Telmisartan—Malaise—Doxorubicin—testicular cancer	0.000113	0.000579	CcSEcCtD
Telmisartan—Dry mouth—Epirubicin—testicular cancer	0.000113	0.000578	CcSEcCtD
Telmisartan—Vertigo—Doxorubicin—testicular cancer	0.000113	0.000577	CcSEcCtD
Telmisartan—Anorexia—Methotrexate—testicular cancer	0.000113	0.000577	CcSEcCtD
Telmisartan—Syncope—Doxorubicin—testicular cancer	0.000113	0.000576	CcSEcCtD
Telmisartan—Palpitations—Doxorubicin—testicular cancer	0.000111	0.000567	CcSEcCtD
Telmisartan—Oedema—Epirubicin—testicular cancer	0.000111	0.000566	CcSEcCtD
Telmisartan—Anaphylactic shock—Epirubicin—testicular cancer	0.000111	0.000566	CcSEcCtD
Telmisartan—Hypotension—Methotrexate—testicular cancer	0.000111	0.000565	CcSEcCtD
Telmisartan—Loss of consciousness—Doxorubicin—testicular cancer	0.000111	0.000564	CcSEcCtD
Telmisartan—Infection—Epirubicin—testicular cancer	0.00011	0.000562	CcSEcCtD
Telmisartan—Cough—Doxorubicin—testicular cancer	0.00011	0.00056	CcSEcCtD
Telmisartan—Shock—Epirubicin—testicular cancer	0.000109	0.000557	CcSEcCtD
Telmisartan—Nervous system disorder—Epirubicin—testicular cancer	0.000109	0.000555	CcSEcCtD
Telmisartan—Thrombocytopenia—Epirubicin—testicular cancer	0.000109	0.000554	CcSEcCtD
Telmisartan—Hypertension—Doxorubicin—testicular cancer	0.000109	0.000554	CcSEcCtD
Telmisartan—Tachycardia—Epirubicin—testicular cancer	0.000108	0.000553	CcSEcCtD
Telmisartan—Musculoskeletal discomfort—Methotrexate—testicular cancer	0.000108	0.000551	CcSEcCtD
Telmisartan—Skin disorder—Epirubicin—testicular cancer	0.000108	0.00055	CcSEcCtD
Telmisartan—Hyperhidrosis—Epirubicin—testicular cancer	0.000107	0.000547	CcSEcCtD
Telmisartan—Insomnia—Methotrexate—testicular cancer	0.000107	0.000547	CcSEcCtD
Telmisartan—Arthralgia—Doxorubicin—testicular cancer	0.000107	0.000546	CcSEcCtD
Telmisartan—Chest pain—Doxorubicin—testicular cancer	0.000107	0.000546	CcSEcCtD
Telmisartan—Myalgia—Doxorubicin—testicular cancer	0.000107	0.000546	CcSEcCtD
Telmisartan—Anxiety—Doxorubicin—testicular cancer	0.000107	0.000545	CcSEcCtD
Telmisartan—Paraesthesia—Methotrexate—testicular cancer	0.000107	0.000543	CcSEcCtD
Telmisartan—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—testicular cancer	0.000106	0.000543	CcSEcCtD
Telmisartan—Discomfort—Doxorubicin—testicular cancer	0.000106	0.00054	CcSEcCtD
Telmisartan—Anorexia—Epirubicin—testicular cancer	0.000106	0.00054	CcSEcCtD
Telmisartan—Dyspnoea—Methotrexate—testicular cancer	0.000106	0.000539	CcSEcCtD
Telmisartan—Somnolence—Methotrexate—testicular cancer	0.000105	0.000538	CcSEcCtD
Telmisartan—Dry mouth—Doxorubicin—testicular cancer	0.000105	0.000534	CcSEcCtD
Telmisartan—Dyspepsia—Methotrexate—testicular cancer	0.000104	0.000533	CcSEcCtD
Telmisartan—Hypotension—Epirubicin—testicular cancer	0.000104	0.000529	CcSEcCtD
Telmisartan—Decreased appetite—Methotrexate—testicular cancer	0.000103	0.000526	CcSEcCtD
Telmisartan—Oedema—Doxorubicin—testicular cancer	0.000103	0.000524	CcSEcCtD
Telmisartan—Anaphylactic shock—Doxorubicin—testicular cancer	0.000103	0.000524	CcSEcCtD
Telmisartan—Gastrointestinal disorder—Methotrexate—testicular cancer	0.000102	0.000522	CcSEcCtD
Telmisartan—Fatigue—Methotrexate—testicular cancer	0.000102	0.000522	CcSEcCtD
Telmisartan—Infection—Doxorubicin—testicular cancer	0.000102	0.00052	CcSEcCtD
Telmisartan—Pain—Methotrexate—testicular cancer	0.000101	0.000517	CcSEcCtD
Telmisartan—Musculoskeletal discomfort—Epirubicin—testicular cancer	0.000101	0.000516	CcSEcCtD
Telmisartan—Shock—Doxorubicin—testicular cancer	0.000101	0.000515	CcSEcCtD
Telmisartan—Nervous system disorder—Doxorubicin—testicular cancer	0.000101	0.000514	CcSEcCtD
Telmisartan—Thrombocytopenia—Doxorubicin—testicular cancer	0.000101	0.000513	CcSEcCtD
Telmisartan—Insomnia—Epirubicin—testicular cancer	0.0001	0.000512	CcSEcCtD
Telmisartan—Tachycardia—Doxorubicin—testicular cancer	0.0001	0.000511	CcSEcCtD
Telmisartan—Skin disorder—Doxorubicin—testicular cancer	9.98e-05	0.000509	CcSEcCtD
Telmisartan—Paraesthesia—Epirubicin—testicular cancer	9.97e-05	0.000508	CcSEcCtD
Telmisartan—Hyperhidrosis—Doxorubicin—testicular cancer	9.93e-05	0.000506	CcSEcCtD
Telmisartan—Dyspnoea—Epirubicin—testicular cancer	9.9e-05	0.000505	CcSEcCtD
Telmisartan—Somnolence—Epirubicin—testicular cancer	9.87e-05	0.000503	CcSEcCtD
Telmisartan—Anorexia—Doxorubicin—testicular cancer	9.79e-05	0.000499	CcSEcCtD
Telmisartan—Feeling abnormal—Methotrexate—testicular cancer	9.77e-05	0.000499	CcSEcCtD
Telmisartan—Dyspepsia—Epirubicin—testicular cancer	9.77e-05	0.000498	CcSEcCtD
Telmisartan—Gastrointestinal pain—Methotrexate—testicular cancer	9.7e-05	0.000495	CcSEcCtD
Telmisartan—Decreased appetite—Epirubicin—testicular cancer	9.65e-05	0.000492	CcSEcCtD
Telmisartan—Hypotension—Doxorubicin—testicular cancer	9.6e-05	0.00049	CcSEcCtD
Telmisartan—Gastrointestinal disorder—Epirubicin—testicular cancer	9.58e-05	0.000489	CcSEcCtD
Telmisartan—Fatigue—Epirubicin—testicular cancer	9.57e-05	0.000488	CcSEcCtD
Telmisartan—Constipation—Epirubicin—testicular cancer	9.49e-05	0.000484	CcSEcCtD
Telmisartan—Pain—Epirubicin—testicular cancer	9.49e-05	0.000484	CcSEcCtD
Telmisartan—Urticaria—Methotrexate—testicular cancer	9.42e-05	0.000481	CcSEcCtD
Telmisartan—Body temperature increased—Methotrexate—testicular cancer	9.38e-05	0.000478	CcSEcCtD
Telmisartan—Abdominal pain—Methotrexate—testicular cancer	9.38e-05	0.000478	CcSEcCtD
Telmisartan—Musculoskeletal discomfort—Doxorubicin—testicular cancer	9.36e-05	0.000477	CcSEcCtD
Telmisartan—Insomnia—Doxorubicin—testicular cancer	9.29e-05	0.000474	CcSEcCtD
Telmisartan—Paraesthesia—Doxorubicin—testicular cancer	9.22e-05	0.00047	CcSEcCtD
Telmisartan—Dyspnoea—Doxorubicin—testicular cancer	9.16e-05	0.000467	CcSEcCtD
Telmisartan—Feeling abnormal—Epirubicin—testicular cancer	9.15e-05	0.000467	CcSEcCtD
Telmisartan—Somnolence—Doxorubicin—testicular cancer	9.13e-05	0.000466	CcSEcCtD
Telmisartan—Gastrointestinal pain—Epirubicin—testicular cancer	9.08e-05	0.000463	CcSEcCtD
Telmisartan—Dyspepsia—Doxorubicin—testicular cancer	9.04e-05	0.000461	CcSEcCtD
Telmisartan—Decreased appetite—Doxorubicin—testicular cancer	8.93e-05	0.000455	CcSEcCtD
Telmisartan—Gastrointestinal disorder—Doxorubicin—testicular cancer	8.87e-05	0.000452	CcSEcCtD
Telmisartan—Fatigue—Doxorubicin—testicular cancer	8.86e-05	0.000452	CcSEcCtD
Telmisartan—Urticaria—Epirubicin—testicular cancer	8.82e-05	0.00045	CcSEcCtD
Telmisartan—Pain—Doxorubicin—testicular cancer	8.78e-05	0.000448	CcSEcCtD
Telmisartan—Constipation—Doxorubicin—testicular cancer	8.78e-05	0.000448	CcSEcCtD
Telmisartan—Body temperature increased—Epirubicin—testicular cancer	8.77e-05	0.000448	CcSEcCtD
Telmisartan—Abdominal pain—Epirubicin—testicular cancer	8.77e-05	0.000448	CcSEcCtD
Telmisartan—Hypersensitivity—Methotrexate—testicular cancer	8.74e-05	0.000446	CcSEcCtD
Telmisartan—Asthenia—Methotrexate—testicular cancer	8.51e-05	0.000434	CcSEcCtD
Telmisartan—Feeling abnormal—Doxorubicin—testicular cancer	8.46e-05	0.000432	CcSEcCtD
Telmisartan—Gastrointestinal pain—Doxorubicin—testicular cancer	8.4e-05	0.000428	CcSEcCtD
Telmisartan—Pruritus—Methotrexate—testicular cancer	8.39e-05	0.000428	CcSEcCtD
Telmisartan—Hypersensitivity—Epirubicin—testicular cancer	8.18e-05	0.000417	CcSEcCtD
Telmisartan—Urticaria—Doxorubicin—testicular cancer	8.16e-05	0.000416	CcSEcCtD
Telmisartan—Abdominal pain—Doxorubicin—testicular cancer	8.12e-05	0.000414	CcSEcCtD
Telmisartan—Body temperature increased—Doxorubicin—testicular cancer	8.12e-05	0.000414	CcSEcCtD
Telmisartan—Diarrhoea—Methotrexate—testicular cancer	8.12e-05	0.000414	CcSEcCtD
Telmisartan—Asthenia—Epirubicin—testicular cancer	7.96e-05	0.000406	CcSEcCtD
Telmisartan—Pruritus—Epirubicin—testicular cancer	7.85e-05	0.000401	CcSEcCtD
Telmisartan—Dizziness—Methotrexate—testicular cancer	7.84e-05	0.0004	CcSEcCtD
Telmisartan—Diarrhoea—Epirubicin—testicular cancer	7.59e-05	0.000387	CcSEcCtD
Telmisartan—Hypersensitivity—Doxorubicin—testicular cancer	7.57e-05	0.000386	CcSEcCtD
Telmisartan—Vomiting—Methotrexate—testicular cancer	7.54e-05	0.000385	CcSEcCtD
Telmisartan—Rash—Methotrexate—testicular cancer	7.48e-05	0.000381	CcSEcCtD
Telmisartan—Dermatitis—Methotrexate—testicular cancer	7.47e-05	0.000381	CcSEcCtD
Telmisartan—Headache—Methotrexate—testicular cancer	7.43e-05	0.000379	CcSEcCtD
Telmisartan—Asthenia—Doxorubicin—testicular cancer	7.37e-05	0.000376	CcSEcCtD
Telmisartan—Dizziness—Epirubicin—testicular cancer	7.34e-05	0.000374	CcSEcCtD
Telmisartan—Pruritus—Doxorubicin—testicular cancer	7.27e-05	0.000371	CcSEcCtD
Telmisartan—Vomiting—Epirubicin—testicular cancer	7.06e-05	0.00036	CcSEcCtD
Telmisartan—Nausea—Methotrexate—testicular cancer	7.05e-05	0.000359	CcSEcCtD
Telmisartan—Diarrhoea—Doxorubicin—testicular cancer	7.03e-05	0.000358	CcSEcCtD
Telmisartan—Rash—Epirubicin—testicular cancer	7e-05	0.000357	CcSEcCtD
Telmisartan—Dermatitis—Epirubicin—testicular cancer	6.99e-05	0.000357	CcSEcCtD
Telmisartan—Headache—Epirubicin—testicular cancer	6.95e-05	0.000355	CcSEcCtD
Telmisartan—Dizziness—Doxorubicin—testicular cancer	6.79e-05	0.000346	CcSEcCtD
Telmisartan—Nausea—Epirubicin—testicular cancer	6.59e-05	0.000336	CcSEcCtD
Telmisartan—Vomiting—Doxorubicin—testicular cancer	6.53e-05	0.000333	CcSEcCtD
Telmisartan—Rash—Doxorubicin—testicular cancer	6.48e-05	0.00033	CcSEcCtD
Telmisartan—Dermatitis—Doxorubicin—testicular cancer	6.47e-05	0.00033	CcSEcCtD
Telmisartan—Headache—Doxorubicin—testicular cancer	6.43e-05	0.000328	CcSEcCtD
Telmisartan—Nausea—Doxorubicin—testicular cancer	6.1e-05	0.000311	CcSEcCtD
